These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31963118)

  • 21. Active Ebola Virus Replication and Heterogeneous Evolutionary Rates in EVD Survivors.
    Whitmer SLM; Ladner JT; Wiley MR; Patel K; Dudas G; Rambaut A; Sahr F; Prieto K; Shepard SS; Carmody E; Knust B; Naidoo D; Deen G; Formenty P; Nichol ST; Palacios G; Ströher U;
    Cell Rep; 2018 Jan; 22(5):1159-1168. PubMed ID: 29386105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Host Factors in Ebola Infection.
    Rasmussen AL
    Annu Rev Genomics Hum Genet; 2016 Aug; 17():333-51. PubMed ID: 27147086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression of Ebola Therapeutics During the 2014-2015 Outbreak.
    Mendoza EJ; Qiu X; Kobinger GP
    Trends Mol Med; 2016 Feb; 22(2):164-173. PubMed ID: 26774636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Interferon Gamma on Ebola Virus Infection of Primary Kupffer Cells and a Kupffer Cell Line.
    Aguilar-Briseño JA; Elliff JM; Patten JJ; Wilson LR; Davey RA; Bailey AL; Maury WJ
    Viruses; 2023 Oct; 15(10):. PubMed ID: 37896854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus.
    Cong Y; Dyall J; Hart BJ; DeWald LE; Johnson JC; Postnikova E; Zhou H; Gross R; Rojas O; Alexander I; Josleyn N; Zhang T; Michelotti J; Janosko K; Glass PJ; Flint M; McMullan LK; Spiropoulou CF; Mierzwa T; Guha R; Shinn P; Michael S; Klumpp-Thomas C; McKnight C; Thomas C; Eakin AE; O'Loughlin KG; Green CE; Catz P; Mirsalis JC; Honko AN; Olinger GG; Bennett RS; Holbrook MR; Hensley LE; Jahrling PB
    PLoS One; 2016; 11(11):e0166318. PubMed ID: 27902714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication.
    Bharaj P; Atkins C; Luthra P; Giraldo MI; Dawes BE; Miorin L; Johnson JR; Krogan NJ; Basler CF; Freiberg AN; Rajsbaum R
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28679761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24.
    Kwofie SK; Broni E; Teye J; Quansah E; Issah I; Wilson MD; Miller WA; Tiburu EK; Bonney JHK
    Comput Biol Med; 2019 Oct; 113():103414. PubMed ID: 31536833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection
    Kummer S; Lander A; Goretzko J; Kirchoff N; Rescher U; Schloer S
    Emerg Microbes Infect; 2022 Dec; 11(1):195-207. PubMed ID: 34919035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo.
    Pessi A; Bixler SL; Soloveva V; Radoshitzky S; Retterer C; Kenny T; Zamani R; Gomba G; Gharabeih D; Wells J; Wetzel KS; Warren TK; Donnelly G; Van Tongeren SA; Steffens J; Duplantier AJ; Kane CD; Vicat P; Couturier V; Kester KE; Shiver J; Carter K; Bavari S
    Antiviral Res; 2019 Nov; 171():104592. PubMed ID: 31473342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severity of Disease in Humanized Mice Infected With Ebola Virus or Reston Virus Is Associated With Magnitude of Early Viral Replication in Liver.
    Spengler JR; Saturday G; Lavender KJ; Martellaro C; Keck JG; Nichol ST; Spiropoulou CF; Feldmann H; Prescott J
    J Infect Dis; 2017 Dec; 217(1):58-63. PubMed ID: 29087482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys.
    Warren TK; Jordan R; Lo MK; Ray AS; Mackman RL; Soloveva V; Siegel D; Perron M; Bannister R; Hui HC; Larson N; Strickley R; Wells J; Stuthman KS; Van Tongeren SA; Garza NL; Donnelly G; Shurtleff AC; Retterer CJ; Gharaibeh D; Zamani R; Kenny T; Eaton BP; Grimes E; Welch LS; Gomba L; Wilhelmsen CL; Nichols DK; Nuss JE; Nagle ER; Kugelman JR; Palacios G; Doerffler E; Neville S; Carra E; Clarke MO; Zhang L; Lew W; Ross B; Wang Q; Chun K; Wolfe L; Babusis D; Park Y; Stray KM; Trancheva I; Feng JY; Barauskas O; Xu Y; Wong P; Braun MR; Flint M; McMullan LK; Chen SS; Fearns R; Swaminathan S; Mayers DL; Spiropoulou CF; Lee WA; Nichol ST; Cihlar T; Bavari S
    Nature; 2016 Mar; 531(7594):381-5. PubMed ID: 26934220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ebola virus dynamics in mice treated with favipiravir.
    Madelain V; Oestereich L; Graw F; Nguyen TH; de Lamballerie X; Mentré F; Günther S; Guedj J
    Antiviral Res; 2015 Nov; 123():70-7. PubMed ID: 26343011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NK Cells Accumulate in Infected Tissues and Contribute to Pathogenicity of Ebola Virus in Mice.
    Fausther-Bovendo H; Qiu X; He S; Bello A; Audet J; Ippolito G; Wong G; Kobinger G
    J Virol; 2019 May; 93(10):. PubMed ID: 30814283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiviral effect of ranpirnase against Ebola virus.
    Hodge T; Draper K; Brasel T; Freiberg A; Squiquera L; Sidransky D; Sulley J; Taxman DJ
    Antiviral Res; 2016 Aug; 132():210-8. PubMed ID: 27350309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of therapeutics for treatment of Ebola virus infection.
    Li H; Ying T; Yu F; Lu L; Jiang S
    Microbes Infect; 2015 Feb; 17(2):109-17. PubMed ID: 25498866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-exposure treatment of non-human primates lethally infected with Ebola virus with EBOTAb, a purified ovine IgG product.
    Dowall SD; Jacquot F; Landon J; Rayner E; Hall G; Carbonnelle C; Raoul H; Pannetier D; Cameron I; Coxon R; Al Abdulla I; Hewson R; Carroll MW
    Sci Rep; 2017 Jun; 7(1):4099. PubMed ID: 28642489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Drug Targets and Antiviral Molecules for Treatment of Ebola Virus Infection.
    Wu W; Liu S
    Curr Top Med Chem; 2017; 17(3):361-370. PubMed ID: 27572081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ebola Virus GP Activates Endothelial Cells via Host Cytoskeletal Signaling Factors.
    Moni BM; Sakurai Y; Yasuda J
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of Viral and Host Biomarkers in the Liver of Rhesus Macaques: A Longitudinal Study of Zaire Ebolavirus Strain Kikwit (EBOV/Kik).
    Greenberg A; Huber BR; Liu DX; Logue JP; Hischak AMW; Hart RJ; Abbott M; Isic N; Hisada YM; Mackman N; Bennett RS; Hensley LE; Connor JH; Crossland NA
    Am J Pathol; 2020 Jul; 190(7):1449-1460. PubMed ID: 32275904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyphenylene carboxymethylene (PPCM) in vitro antiviral efficacy against Ebola virus in the context of a sexually transmitted infection.
    Escaffre O; Juelich TL; Freiberg AN
    Antiviral Res; 2019 Oct; 170():104567. PubMed ID: 31351092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.